Clinical management of patients with <i>ASXL1</i> mutations and Bohring–Opitz syndrome, emphasizing the need for Wilms tumor surveillance
Bianca Russell(University of California, Los Angeles), John M. Graham(Cedars-Sinai Medical Center), L. Kate Clarkson(Greenwood Genetic Center), Avi Z. Rosenberg(Johns Hopkins University), Angela Pickart(Children's Hospital of Wisconsin), Catherine A. Brownstein(Boston Children's Hospital), Samantha A. Schrier Vergano(Children's Hospital of The King's Daughters), Wen‐Hann Tan(Boston Children's Hospital), Amy Dobson(Greenwood Genetic Center), Nancy Kramer(Cedars-Sinai Medical Center), Rachel Harrison(Nottingham University Hospitals NHS Trust), Leslie G. Biesecker(National Institutes of Health), William J. Rhead(Children's Hospital of Wisconsin), Jennifer J. Johnston(National Institutes of Health), Benjamin M. Helm(Indiana University School of Medicine)
Cited by 66
Related Papers
De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes
|Nature Genetics|2012|752
Sharing Health Data for Better Outcomes on PatientsLikeMe
|Journal of Medical Internet Research|2010|635
Angelman and Prader‐Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion
|American Journal of Medical Genetics|1989|583
CHARGE Association: An Update and Review for the Primary Pediatrician
|Clinical Pediatrics|1998|451